Skip to main content
. 2016 Sep 13;13(9):e1002124. doi: 10.1371/journal.pmed.1002124

Table 1. Baseline characteristics (intention to treat population).

Characteristic Paucigravidae Multigravidae All Gravidae (Pooled)
ISTp-DP (n = 571) IPTp-SP (n = 569) ISTp-DP (n = 352) IPTp-SP (n = 352) ISTp-DP (n = 923) IPTp-SP (n = 921)
Maternal characteristics
Study site
Madziabango 21.9% (125/571) 22.1% (126/569) 31.3% (110/352) 30.4% (107/352) 25.5% (235/923) 25.3% (233/921)
Mpemba 51.5% (294/571) 51.5% (293/569) 54.3% (191/352) 55.4% (195/352) 52.6% (485/923) 53.0% (488/921)
Chikwawa 26.6% (152/571) 26.4% (150/569) 14.5% (51/352) 14.2% (50/352) 22.0% (203/923) 21.7% (200/921)
Maternal age (years) 19.5 (2.7) 19.6 (2.8) 27.3 (4.3) 27.5 (4.2) 22.5 (5.1) 22.6 (5.1)
Marital status
Single 8.1% (46/570) 8.8% (50/569) 2.0% (7/351) 0.3% (1/352) 5.8% (53/921) 5.5% (51/921)
Married 91.9% (524/570) 91.2% (519/569) 97.7% (343/351) 99.1.% (349/352) 94.1% (867/921) 94.2% (868/921)
Widowed/separated/divorced 0.0% (0/570) 0.0% (0/569) 0.3% (1/351) 0.6% (2/352) 0.1% (1/921) 0.2% (2/921)
Used a bednet last night 18.2% (104/571) 17.0% (97/569) 18.2% (64/351) 24.1% (85/352) 18.2% (168/922) 19.8% (182/921)
Schooling (years completed) 6.7 (3.4) 6.7 (3.3) 4.4 (3.4) 4.4 (3.9) 5.8 (3.6) 5.9 (3.7)
SES index score (terciles)
Low 34.7% (198/570) 33.3% (189/567) 33.3% (117/351) 31.5% (111/352) 34.2% (315/921) 32.6% (300/919)
Medium 31.2% (178/570) 32.1% (182/567) 37.0% (130/351) 36.1% (127/352) 33.4% (308/921) 33.6% (309/919)
High 34.0% (194/570) 34.6% (196/567) 29.6% (104/351) 32.4% (114/352) 32.4% (298/921) 33.7% (310/919)
Rainfall in the 3 mo before enrollment (average/month, in millimeters) 22.8 (3.0–117.5) 22.8 (3.0–117.5) 23.8 (3.3–117.5) 24.7 (3.3–117.5) 22.8 (3.3–117.5) 22.8 (3.3–117.5)
Pregnancy number (gravidity)
First 54.5% (311/571) 55.5% (316/569) NA NA 33.8% (311/921) 34.3% (316/920)
Second 45.5% (260/571) 44.5% (253/569) NA NA 28.2% (260/921) 27.5% (253/920)
Third NA NA 44.0% (154/352) 43.0% (151/351) 16.7% (154/921) 16.4% (151/920)
Fourth or higher NA NA 56.0% (196/352) 57.0% (200/351) 21.3% (196/921) 21.7% (200/920)
Gestational age by ultrasound (days) 145.1 (23.0) 144.5 (22.4) 149.7 (23.7) 149.1 (23.8) 146.8 (23.3) 146.2 (23.0)
Had a previous stillbirth/abortion 5.1% (29/571) 4.0% (23/569) 14.2% (50/352) 10.8% (38/352) 8.6% (79/923) 6.6% (61/921)
Maternal weight (kilograms) 54.1 (6.8) 54.4 (6.9) 56.1 (7.5) 57.0 (8.5) 54.8 (7.2) 55.4 (7.6)
Maternal height (centimeters) 153.6 (4.8) 154.0 (5.0) 154.2 (5.2) 154.5 (5.0) 153.8 (5.0) 154.2 (5.0)
Laboratory findings
Hemoglobin (g/dl)  10.7 (1.5) 10.7 (1.5)  11.5 (1.3) 11.5 (1.3) 11.0 (1.5) 11.0 (1.4) 
Plasmodium infection  
RDT  43.8% (250/571) NA  19.4% (68/351)  NA  34.5% (318/922)  NA 
Microscopy 17.7% (100/565) 20.8% (117/562) 11.8% (41/347) 9.4% (33/351) 15.5% (141/912) 16.4% (150/913)
PCR 51.3% (285/556) 51.7% (290/561) 33.1% (115/347) 28.7% (98/342) 44.3% (400/903) 43.0% (388/903)
Microscopy or PCR 52.5% (300/571) 54.9% (312/568) 36.4% (128/352) 31.5% (111/352) 46.4% (428/923) 46.0% (423/920)
Parasite density a 1,000 (320–7,200) 2,427 (507–9,600) 320 (160–3,200) 907 (213–4,267) 800 (267–5,867) 2,400 (320–8,000)

Data are percent (n/N), mean (standard deviation), or median (interquartile range).

aParasite density per microliter, assessed by microscopy.

IPTp-SP, intermittent preventive therapy in pregnancy with sulfadoxine-pyrimethamine; ISTp-DP, intermittent screening and treatment in pregnancy with dihydroartemisinin-piperaquine; NA, not applicable; RDT, rapid diagnostic test; SES, socioeconomic status.